Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-660-8 | CAS number: 2492-26-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute dermal and oral toxicity of the test substance SMBT (50%) is very low, indicated by LD50 values greater than 2000 mg/kg bw. The acute oral LD50 value in rats is 2100 mg/kg bw (Bayer AG 1978) and the dermal LD50 value in rabbits is greater than 7940 mg/kg bw for SMBT (50%) (Monsanto Co. 1974).
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 100 mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 7 940 mg/kg bw
Additional information
Acute toxicity: oral
The acute oral toxicity of SMBT was evaluated in acute oral toxicity studies in rats. Although the study results are reliable the test design of the studies does not comply with the current guidelines.
In an acceptable documented study with male Wistar rats undiluted SMBT solution (50%) was administered by gavage to male Wistar rats at doses of 0.5, 1.0, 2.0, 3.1, 3.5, 4.0, and 5.0 ml/kg bw (ca. 400, 800, 1600, 2480, 2800, 3200, 4000 mg/kg bw). A 14-day observation period followed administration. The oral LD50 calculated was 2.63 ml/kg bw (ca. 2100 mg/kg bw). Mortality occurred at 800 mg/kg bw and higher (1/10, 2/10, 4/10, 8/10, 8/10, 10/10 at 800, 1600, 2480, 2800, 3200, 4000 mg/kg bw, respectively). Clinical signs were observed and included sedation, difficulties in respiration and myoclonus.
In another acute toxicity study with rats, a LD50 value of 4350 mg/kg bw was calculated (Monsanto Co. 1974). Male and female Sprague Dawley rats (5 animals per dose) were administered once by gavage with the undiluted test substance SMBT (50%) at doses of 2510, 3160, 3980 and 5010 mg/kg bw. A 14-day observation period followed administration. Mortality occurred (one hour to one days after application) in the mid and higher dose groups evaluated (2/5, 2/5, 4/5 at 3160, 3980, 5010 mg/kg bw, respectively). Clinical signs were observed and included reduced appetite and activity (lasting up to one day in survivors), rapidly increasing weakness, tremors, convulsions, collapse, and death. Autopsy of decedent showed hemorrhagic areas of the lungs, liver hyperemia, and acute gastrointestinal inflammation; viscera of surviving animals appeared normal at sacrifice (Monsanto Co. 1974).
In another acceptable documented acute oral toxicity study with Sprague-Dawley rats, an oral LD50 of 9500 mg/kg bw was calculated for SMBT (22%) (Monsanto Co. 1979).
Acute toxicity: dermal
The acute dermal toxicity of SMBT (50%) was evaluated in a limited but acceptable documented acute dermal toxicity study with New Zealand Albino rabbits (Monsanto Co. 1974). One male was treated with 5010 mg/kg and one male and one female with 7940 mg/kg bw undiluted SMBT (50%) for 24 hours. No mortality occurred during the study. Clinical signs observed included reduced appetite and activity (four to seven days). Gross autopsy at study termination revealed no abnormalities in viscera in the treated animals. A dermal LD50 value greater than 7940 mg/kg bw is suggested.
In another dermal toxicity study with rabbits a dermal LD 50 value greater 7940 mg/kg bw was suggested for SMBT solution (22%). One male was treated with 5010 mg/kg and one male and one female with 7940 mg/kg bw undiluted sodium MBT (22%) for 24 hours. No mortality occurred. Clinical signs observed were weight loss for two to four days. Gross autopsy at study termination revealed no abnormalities in viscera in the treated animals.
Justification for classification or non-classification
No classification is required according to the classification criteria 67/548/EWG and regulation no. 1272/2008 (GHS).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.